Spanish Society of Hospital Pharmacy position paper on biosimilar medicines
Biological medicines nowadays have a great impact, as they offer treatment for diverse diseases and suppose a high cost for health system. Biosimilar medicines contain a version of an active substance already authorized as an original biotechnological medicine, whose patent has expired, and they c...
Saved in:
| Main Authors: | Noemí Martínez-López de Castro, María Belén Matilla-Fernández, María Dolores Fraga-Fuentes, Irene Mangues-Bafalluy, Rocío Asensi-Díez, Gerardo Cajaraville-Ordoñana |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-07-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10973.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of rheumatologists’ knowledge of biosimilars
by: Thayane Furtado Rolim Lima, et al.
Published: (2025-07-01) -
Biosimilars: presumption of guilt
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-12-01) -
BIOSIMILARS IN RHEUMATOLOGY
by: E. L. Nasonov
Published: (2017-01-01) -
Biosimilars Targeting Pathogens: A Comprehensive Review of Their Role in Bacterial, Fungal, Parasitic, and Viral Infections
by: Mohamed Halawa, et al.
Published: (2025-04-01) -
Call for Papers - Advancing Astropharmacy and Sports Pharmacy
by: Ashley Anderson, et al.
Published: (2025-02-01)